MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 0.6% of their position (915.00 shares) of NATERA, INC. on the open market
Open‑market sale worth $186.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0002010019-26-000008
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
+859.00
Net shares
Net buyer
$186.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.77K acquired · 915.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.77K
Price / share
—
Trade value
—
% of position
1.2%
3/9/2026
150.02K→151.80K
Common Stock
Direct
Shares
−915.00
Price / share
$204.13
Trade value
$186.78K
% of position
0.6%
3/10/2026
151.80K→150.88K
Total
Net shares
+859.00
Net value
-$186.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | A · Award | +1.77K | — | — | 1.2% | 150.02K | 151.80K |
| Common Stock Direct | 3/10/2026 | S · Sale | −915.00 | $204.13 | $186.78K | 0.6% | 151.80K | 150.88K |
| Total | +859.00 | -$186.78K | ||||||
Derivative Transactions0
No derivative transactions reported